UB Paderborn / Katalog / Suche / in CDI

OUTREACH: PRELIMINARY SAFETY & EFFICACY RESULTS FROM A PHASE 2 STUDY OF LISOCABTAGENE MARALEUCEL (LISO‐CEL) IN THE NONUNIVERSITY SETTING

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

P1455: FIRST‐IN‐HUMAN TRIAL OF CB‐010, A CRISPR‐EDITED ALLOGENEIC ANTI‐CD19 CAR ‐T CELL THERAPY WITH A PD‐1 KNOCK OUT, IN PATIENTS WITH RELAPSED OR REFRACTORY B CELL NON‐HODGKIN LYMPHOMA (ANTLER STUDY)

HemaSphere, 2022-06, Vol.6 (Suppl), p.1337-1338

2022

Volltextzugriff (PDF)

S258: LISOCABTAGENE MARALEUCEL (LISO‐CEL) AS SECOND‐LINE THERAPY FOR R/R LARGE B‐CELL LYMPHOMA (LBCL) IN PATIENTS NOT INTENDED FOR HSCT: PRIMARY ANALYSIS FROM THE PHASE 2 PILOT STUDY

HemaSphere, 2022-06, Vol.6, p.159-160

2022

Volltextzugriff (PDF)

Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial

Annals of internal medicine, 1998-06, Vol.128 (12 Pt 1), p.975

1998

Volltextzugriff (PDF)

Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma

Haematologica (Roma), 2015-05, Vol.100 (5), p.670

2015

Volltextzugriff (PDF)

Bendamustine, Bortezomib and Dexamethasone (BBD) As First-Line Treatment of Patients (Pts) with Multiple Myeloma (MM) Who Are Not Candidates for High Dose Chemotherapy

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e70-e71

2015

Volltextzugriff (PDF)

Community-Based Phase IIIB Trial of Three UPFRONT Bortezomib-Based Myeloma Regimens

Journal of clinical oncology, 2015-11, Vol.33 (33), p.3921-3929

2015

Volltextzugriff (PDF)

Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2018-05, Vol.391 (10135), p.2116-2127

2018

Volltextzugriff (PDF)

Safety and efficacy of polatuzumab vedotin + obinutuzumab for relapsed/refractory NHL: A phase IB/II study

American journal of hematology, 2022-01, Vol.97, p.E24-E27

2022

Volltextzugriff (PDF)

Comparison of thromboelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass

Journal of cardiothoracic and vascular anesthesia, 1993, Vol.7 (4), p.410-415

1993

Volltextzugriff (PDF)

Diversity of organ site involvement among malignant lymphomas of mucosa-associated tissues

American journal of clinical pathology, 1991-12, Vol.96 (6), p.738-745

1991

Volltextzugriff (PDF)

Marked Increase in Veno-Occlusive Disease of the Liver Associated With Methotrexate Use for Graft-Versus-Host Disease Prophylaxis in Patients Receiving Busulfan/Cyclophosphamide

Blood, 1992-05, Vol.79 (10), p.2784-2788

1992

Volltextzugriff (PDF)

Oral cavity complications of bone marrow transplantation

Seminars in cutaneous medicine and surgery, 1997-12, Vol.16 (4), p.265-272

1997

Volltextzugriff (PDF)

PS1533 KD025–208: A PHASE 2A TRIAL OF KD025 FOR PATIENTS WITH CHRONIC GRAFT‐VERSUS‐HOST DISEASE (CGVHD) – UPDATED SAFETY AND EFFICACY

HemaSphere, 2019-06, Vol.3 (S1), p.707-708

2019

Volltextzugriff (PDF)

Diversity of organ site involvement among malignant lymphomas of mucosa-associated tissues

American journal of clinical pathology, 1991-12, Vol.96 (6), p.738-745

1991

Volltextzugriff (PDF)

Pilot trial of prophylactic ursodiol to decrease the incidence of veno-occlusive disease of the liver in allogeneic bone marrow transplant patients

Bone marrow transplantation (Basingstoke), 1992-10, Vol.10 (4), p.367-372

1992

Volltextzugriff (PDF)

Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy

Bone marrow transplantation (Basingstoke), 2003-01, Vol.31 (1), p.51-55

2003

Volltextzugriff (PDF)

Abciximab-associated profound thrombocytopenia : Therapy with immunoglobulin and platelet transfusion

The American journal of cardiology, 1996-11, Vol.78 (10), p.1161-1163

1996

Volltextzugriff (PDF)

Carmustine, Ara C, cyclophosphamide and etoposide with autologous bone marrow transplantation in relapsed or refractory lymphoma : a dose-finding study

Bone marrow transplantation (Basingstoke), 1994-10, Vol.14 (4), p.595-600

1994

Volltextzugriff (PDF)

Chemotherapy administration associated errors before and after use of electronic order entry and decision support

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.19528-19528

2007

Volltextzugriff (PDF)

Phase II trial of vinorelbine for relapsed ovarian cancer: a Southwest Oncology Group study

Gynecologic oncology, 2004-12, Vol.95 (3), p.506-512

2004

Volltextzugriff (PDF)

Abciximab-associated profound thrombocytopenia: Therapy with immunoglobulin and platelet transfusion

The American journal of cardiology, 1996, Vol.78 (10), p.1161-1163

1996

Volltextzugriff (PDF)

Drug-induced thrombocytopenia presenting with isolated oral lesions: report of two cases

Cutis (New York, N.Y.), 1998-10, Vol.62 (4), p.193

1998

Volltextzugriff (PDF)

177Outcome of patients treated with high dose melphalan with or without TBI followed by CD34 selected stem cell rescue using the Baxter Isolex 3001

Biology of blood and marrow transplantation, 2003-02, Vol.9 (2), p.118-118

2003

Volltextzugriff (PDF)

246Ambisome® I mg/kg/day as empiric antifungal therapy in patients with prolonged neutropenia and fever

Biology of blood and marrow transplantation, 2003-02, Vol.9 (2), p.134-135

2003

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

OUTREACH: PRELIMINARY SAFETY & EFFICACY RESULTS FROM A PHASE 2 STUDY OF LISOCABTAGENE MARALEUCEL (LISO‐CEL) IN THE NONUNIVERSITY SETTING

P1455: FIRST‐IN‐HUMAN TRIAL OF CB‐010, A CRISPR‐EDITED ALLOGENEIC ANTI‐CD19 CAR ‐T CELL THERAPY WITH A PD‐1 KNOCK OUT, IN PATIENTS WITH RELAPSED OR REFRACTORY B CELL NON‐HODGKIN LYMPHOMA (ANTLER STUDY)

S258: LISOCABTAGENE MARALEUCEL (LISO‐CEL) AS SECOND‐LINE THERAPY FOR R/R LARGE B‐CELL LYMPHOMA (LBCL) IN PATIENTS NOT INTENDED FOR HSCT: PRIMARY ANALYSIS FROM THE PHASE 2 PILOT STUDY

Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial

Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma

Bendamustine, Bortezomib and Dexamethasone (BBD) As First-Line Treatment of Patients (Pts) with Multiple Myeloma (MM) Who Are Not Candidates for High Dose Chemotherapy

Community-Based Phase IIIB Trial of Three UPFRONT Bortezomib-Based Myeloma Regimens

Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial

Safety and efficacy of polatuzumab vedotin + obinutuzumab for relapsed/refractory NHL: A phase IB/II study

Comparison of thromboelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass

Diversity of organ site involvement among malignant lymphomas of mucosa-associated tissues

Marked Increase in Veno-Occlusive Disease of the Liver Associated With Methotrexate Use for Graft-Versus-Host Disease Prophylaxis in Patients Receiving Busulfan/Cyclophosphamide

Oral cavity complications of bone marrow transplantation

PS1533 KD025–208: A PHASE 2A TRIAL OF KD025 FOR PATIENTS WITH CHRONIC GRAFT‐VERSUS‐HOST DISEASE (CGVHD) – UPDATED SAFETY AND EFFICACY

Diversity of organ site involvement among malignant lymphomas of mucosa-associated tissues

Pilot trial of prophylactic ursodiol to decrease the incidence of veno-occlusive disease of the liver in allogeneic bone marrow transplant patients

Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy

Abciximab-associated profound thrombocytopenia : Therapy with immunoglobulin and platelet transfusion

Carmustine, Ara C, cyclophosphamide and etoposide with autologous bone marrow transplantation in relapsed or refractory lymphoma : a dose-finding study

Chemotherapy administration associated errors before and after use of electronic order entry and decision support

Phase II trial of vinorelbine for relapsed ovarian cancer: a Southwest Oncology Group study

Abciximab-associated profound thrombocytopenia: Therapy with immunoglobulin and platelet transfusion

Drug-induced thrombocytopenia presenting with isolated oral lesions: report of two cases

177Outcome of patients treated with high dose melphalan with or without TBI followed by CD34 selected stem cell rescue using the Baxter Isolex 3001

246Ambisome® I mg/kg/day as empiric antifungal therapy in patients with prolonged neutropenia and fever

Suchergebnisse filtern